Wei-Li Zhao

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Venues

Molecular cancer

Clinical epigenetics

American journal of hematology

Journal of hematology & oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jing-Quan Lim, Dachuan Huang, Jason Yongsheng Chan, Yurike Laurensia, Esther Kam Yin Wong, Daryl Ming Zhe Cheah, Burton Kuan Hui Chia, Wen-Yu Chuang, Ming-Chung Kuo, Yi-Jiun Su, Qing-Qing Cai, Yanfen Feng, Huilan Rao, Li-Na Feng, Pan-Pan Wei, Jie-Rong Chen, Bo-Wei Han, Guo-Wang Lin, Jun Cai, Yu Fang, Jing Tan, Huangming Hong, Yanhui Liu, Fen Zhang, Wenyu Li, Michelle L M Poon, Siok Bian Ng, Anand Jeyasekharan, Jeslin Chian Hung Ha, Lay Poh Khoo, Suk Teng Chin, Wan Lu Pang, Rebecca Kee, Chee Leong Cheng, Nicholas Francis Grigoropoulos, Tiffany Tang, Miriam Tao, Mohamad Farid, Kia Joo Puan, Jie Xiong, Wei-Li Zhao, Chiea Chuen Khor, William Hwang, Won Seog Kim, Elias Campo, Patrick Tan, Bin Tean Teh, Wee-Joo Chng, Olaf Rötzschke, Thomas Tousseyn, Hui-Qiang Huang, Steve Rozen, Soon Thye Lim, Lee-Yung Shih, Jin-Xin Bei, Choon Kiat Ong
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort. American journal of hematology 97 (9) (2022)
Chen-Xing Zhao, Zi-Xun Yan, Jing-Jing Wen, Di Fu, Peng-Peng Xu, Li Wang, Shu Cheng, Jian-da Hu, Wei-Li Zhao
CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis. Molecular cancer 20 (1) (2021)
Mu-Chen Zhang, Ying Fang, Li Wang, Shu Cheng, Di Fu, Yang He, Yan Zhao, Chao-Fu Wang, Xu-Feng Jiang, Qi Song, Peng-Peng Xu, Wei-Li Zhao
Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma. Clinical epigenetics 12 (1) (2020)
Zhong Zheng, Rui Sun, Hui-Jin Zhao, Di Fu, Hui-Juan Zhong, Xiang-Qin Weng, Bin Qu, Yan Zhao, Li Wang, Wei-Li Zhao
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells. Molecular cancer 18 (1) (2019)
Jie Xiong, Wei-Li Zhao
Advances in multiple omics of natural-killer/T cell lymphoma. Journal of hematology & oncology 11 (1) (2018)
Qing Shi, Rong Shen, Chao-Fu Wang, Xing Fan, Ying Qian, Bin-Shen Ou-Yang, Yan Zhao, Christophe Leboeuf, Anne Janin, Shu Cheng, Li Wang, Wei-Li Zhao
Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients. Mediators of inflammation 2017 (2017)

Wei-Li Zhao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wei-Li Zhao